1. KD Tripathi MD. Drugs affecting renin-angiotensin system and plasma kinins. Essentials of Medical Pharmacology 7th ed. New Delhi, May 2013. Page - 507.
2. Pfeffer MA, Opie LH. Inhibitors of the Renin-Angiotensin-Aldosterone System. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. Page - 158.
3. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. Page - 1017.
4. K O Stumpe & M Ludwig. Antihypertensive efficacy of olmesartan compared with other antihypertensive drugs: Journal of human hypertension. April 24, 2002 [Accessed Oct 17, 2020] https://www.nature.com/articles/1001395
5. Mylan Hungary Kft, Electronic Medicines Compendium (EMC); [Revised April 2017] [Accessed Oct 17, 2020] https://www.medicines.org.uk/emc/files/pil.8787.pdf
6. Daiichi Sankyo, Inc. 2002; U.S. Food & Drug Administration; [Revised on 2009] [Accessed Oct 17, 2020] https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021286s023lbl.pdf